Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 402

1.

Decreased pathology and prolonged survival of human DC-SIGN transgenic mice during mycobacterial infection.

Schaefer M, Reiling N, Fessler C, Stephani J, Taniuchi I, Hatam F, Yildirim AO, Fehrenbach H, Walter K, Ruland J, Wagner H, Ehlers S, Sparwasser T.

J Immunol. 2008 May 15;180(10):6836-45.

2.

Mycobacterium bovis Bacillus Calmette-Guerin infects DC-SIGN- dendritic cell and causes the inhibition of IL-12 and the enhancement of IL-10 production.

Gagliardi MC, Teloni R, Giannoni F, Pardini M, Sargentini V, Brunori L, Fattorini L, Nisini R.

J Leukoc Biol. 2005 Jul;78(1):106-13. Epub 2005 Apr 21.

PMID:
15845642
3.

In vivo targeting of human DC-SIGN drastically enhances CD8⁺ T-cell-mediated protective immunity.

Hesse C, Ginter W, Förg T, Mayer CT, Baru AM, Arnold-Schrauf C, Unger WW, Kalay H, van Kooyk Y, Berod L, Sparwasser T.

Eur J Immunol. 2013 Oct;43(10):2543-53. doi: 10.1002/eji.201343429. Epub 2013 Jul 22.

4.

A fatal attraction: Mycobacterium tuberculosis and HIV-1 target DC-SIGN to escape immune surveillance.

van Kooyk Y, Appelmelk B, Geijtenbeek TB.

Trends Mol Med. 2003 Apr;9(4):153-9. Review.

PMID:
12727141
5.

Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells.

Appelmelk BJ, van Die I, van Vliet SJ, Vandenbroucke-Grauls CM, Geijtenbeek TB, van Kooyk Y.

J Immunol. 2003 Feb 15;170(4):1635-9.

6.

DC-SIGN, but not sDC-SIGN, can modulate IL-2 production from PMA- and anti-CD3-stimulated primary human CD4 T cells.

Martinez O, Brackenridge S, El-Idrissi Mel-A, Prabhakar BS.

Int Immunol. 2005 Jun;17(6):769-78. Epub 2005 Jun 8.

PMID:
15944195
7.

PU.1 regulates the tissue-specific expression of dendritic cell-specific intercellular adhesion molecule (ICAM)-3-grabbing nonintegrin.

Domínguez-Soto A, Puig-Kröger A, Vega MA, Corbí AL.

J Biol Chem. 2005 Sep 30;280(39):33123-31. Epub 2005 Jul 28.

8.
9.

Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.

Singh SK, Stephani J, Schaefer M, Kalay H, García-Vallejo JJ, den Haan J, Saeland E, Sparwasser T, van Kooyk Y.

Mol Immunol. 2009 Dec;47(2-3):164-74. doi: 10.1016/j.molimm.2009.09.026. Epub 2009 Oct 8.

PMID:
19818504
10.

Mycobacteria target DC-SIGN to suppress dendritic cell function.

Geijtenbeek TB, Van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CM, Appelmelk B, Van Kooyk Y.

J Exp Med. 2003 Jan 6;197(1):7-17.

11.

DC-SIGN and mannosylated surface structures of Mycobacterium tuberculosis: a deceptive liaison.

Ehlers S.

Eur J Cell Biol. 2010 Jan;89(1):95-101. doi: 10.1016/j.ejcb.2009.10.004. Epub 2009 Nov 4. Review.

PMID:
19892432
12.

The DC-SIGN of zebrafish: insights into the existence of a CD209 homologue in a lower vertebrate and its involvement in adaptive immunity.

Lin AF, Xiang LX, Wang QL, Dong WR, Gong YF, Shao JZ.

J Immunol. 2009 Dec 1;183(11):7398-410. doi: 10.4049/jimmunol.0803955. Epub 2009 Nov 4.

13.

Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes.

van Montfort T, Nabatov AA, Geijtenbeek TB, Pollakis G, Paxton WA.

J Immunol. 2007 Mar 1;178(5):3177-85.

14.

[The correlation between dendritic cell-specific ICAM-3 grabbing nonintegrin expression and Mycobacterium tuberculosis in humans].

Zhang J, Guo SL, Luo YA.

Zhonghua Jie He He Hu Xi Za Zhi. 2009 Aug;32(8):572-5. Chinese.

PMID:
19958673
15.

Activation of human monocyte-derived dendritic cells by Burkholderia pseudomallei does not require binding to the C-type lectin DC-SIGN.

Charoensap J, Engering A, Utaisincharoen P, van Kooyk Y, Sirisinha S.

Trans R Soc Trop Med Hyg. 2008 Dec;102 Suppl 1:S76-81. doi: 10.1016/S0035-9203(08)70020-8.

PMID:
19121694
16.

DC-SIGN: escape mechanism for pathogens.

van Kooyk Y, Geijtenbeek TB.

Nat Rev Immunol. 2003 Sep;3(9):697-709. Review.

PMID:
12949494
17.
18.

Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses.

Dakappagari N, Maruyama T, Renshaw M, Tacken P, Figdor C, Torensma R, Wild MA, Wu D, Bowdish K, Kretz-Rommel A.

J Immunol. 2006 Jan 1;176(1):426-40.

19.

Measles virus targets DC-SIGN to enhance dendritic cell infection.

de Witte L, Abt M, Schneider-Schaulies S, van Kooyk Y, Geijtenbeek TB.

J Virol. 2006 Apr;80(7):3477-86.

20.

Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.

Unger WW, van Beelen AJ, Bruijns SC, Joshi M, Fehres CM, van Bloois L, Verstege MI, Ambrosini M, Kalay H, Nazmi K, Bolscher JG, Hooijberg E, de Gruijl TD, Storm G, van Kooyk Y.

J Control Release. 2012 May 30;160(1):88-95. doi: 10.1016/j.jconrel.2012.02.007. Epub 2012 Feb 15.

PMID:
22366522

Supplemental Content

Support Center